Noncanonical TRAIL Signaling Promotes Myeloid-Derived Suppressor Cell Abundance and Tumor Growth in Cholangiocarcinoma-Reference-Cited by-同舟云学术

Noncanonical TRAIL Signaling Promotes Myeloid-Derived Suppressor Cell Abundance and Tumor Growth in Cholangiocarcinoma

Published:2024 Issue:5 Volume:17 Page:853-876
ISSN:2352-345X
Container-title:Cellular and Molecular Gastroenterology and Hepatology
language:en
Short-container-title:Cellular and Molecular Gastroenterology and Hepatology

Author:

Loeuillard Emilien J.,Li Binbin,Stumpf Hannah E.,Yang Jingchun,Willhite Jessica R.,Tomlinson Jennifer L.,Rohakhtar Fred Rakhshan,Simon Vernadette A.,Graham Rondell P.,Smoot Rory L.,Dong Haidong,Ilyas Sumera I.^ORCID

Funder

Cholangiocarcinoma Foundation

Publisher

Elsevier BV

Reference60 articles.

1. Exploring the TRAILs less travelled: TRAIL in cancer biology and therapy;von Karstedt;Nat Rev Cancer,2017

2. The receptor for the cytotoxic ligand TRAIL;Pan;Science,1997

3. TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL;Walczak;EMBO J,1997

4. Molecular cloning and functional analysis of the mouse homologue of the KILLER/DR5 tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor;Wu;Cancer Res,1999

5. The TRAIL-induced cancer secretome promotes a tumor-supportive immune microenvironment via CCR2;Hartwig;Mol Cell,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of TRAIL Signaling in Cancer: Searching for New Therapeutic Strategies;Biology;2024-07-15

2. Focusing on the Immune Cells: Recent Advances in Immunotherapy for Biliary Tract Cancer;Cancer Management and Research;2024-07

3. Trailblazing TRAIL Therapy: Illuminating Pathways for Cholangiocarcinoma Treatment;Cellular and Molecular Gastroenterology and Hepatology;2024